Distinguished in Synovial Sarcoma

Sebastian J. Bauer

Essen, NW, DE 
Distinguished in Synovial Sarcoma
Essen, NW, DE 
OverviewLocationsClinical Research

Overview

Sebastian Bauer practices in Essen, Germany. Mr. Bauer is rated as a Distinguished expert by MediFind in the treatment of Synovial Sarcoma. His top areas of expertise are Gastrointestinal Stromal Tumor, Adult Soft Tissue Sarcoma, Synovial Sarcoma, Osteotomy, and Heart Transplant.

His clinical research consists of co-authoring 322 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 10 articles in the study of Synovial Sarcoma.

Gender
Male

Locations

Essen, NW, Germany
Other Locations
Heidelberg, BW, Germany
Kiel, SH 24118, Germany
Aachen, NW, Germany
Munich, BY, Germany
Duesseldorf, NW 40225, Germany
Frankfurt Am Main, HE 60528, Germany
Freising, BY 85354, Germany
Marburg An Der Lahn, HE 35037, Germany
Duisburg, NW, Germany
Dresden, SN, Germany
Germany
Forchheim, BY, Germany
Alexander, NW, Germany
Erlangen, BY, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)
An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)
Enrollment Status: Completed
Publish Date: October 06, 2022
Intervention Type: Drug
Study Drugs: Avapritinib, Regorafenib
Study Phase: Phase 3
Single-arm, Multicenter, Open Label Phase II Trial to Evaluate the Efficacy of Pazopanib in Combination With Paclitaxel in Advanced and Relapsed Angiosarcoma
Single-arm, Multicenter, Open Label Phase II Trial to Evaluate the Efficacy of Pazopanib in Combination With Paclitaxel in Advanced and Relapsed Angiosarcoma
Enrollment Status: Terminated
Publish Date: March 22, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Phase 1b Study of Olaratumab, Doxorubicin and Ifosfamide in the Treatment of Patients With Advanced or Metastatic Soft Tissue Sarcoma
A Phase 1b Study of Olaratumab, Doxorubicin and Ifosfamide in the Treatment of Patients With Advanced or Metastatic Soft Tissue Sarcoma
Enrollment Status: Completed
Publish Date: September 10, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 2 Less Clinical Trials

322 Total Publications

Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus Review.
Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus Review.
Journal: JAMA oncology
Published: October 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bauer's expertise for a condition
ConditionClose
View All 15 Advanced Conditions
View All 46 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile